Literature DB >> 11390485

Bcl-2 targets protein phosphatase 1 alpha to Bad.

V Ayllón1, X Cayla, A García, F Roncal, R Fernández, J P Albar, C Martínez, A Rebollo.   

Abstract

The diverse forms of protein phosphatase 1 (PP1) in vivo result from the association of the catalytic subunit with different regulatory subunits. We recently have described that PP1alpha is a Ras-activated Bad phosphatase that regulates IL-2 deprivation-induced apoptosis. With the yeast two-hybrid system, GST fusion proteins, indirect immunofluorescence, and coimmunoprecipitation, we found that Bcl-2 interacts with PP1alpha and Bad. In contrast, Bad did not interact with 14-3-3 protein. Bcl-2 depletion decreased phosphatase activity and association of PP1alpha to Bad. Bcl-2 contains the RIVAF motif, analogous to the well characterized R/KXV/IXF consensus motif shared by most PP1-interacting proteins. This sequence is involved in the binding of Bcl-2 to PP1alpha. Disruption of Bcl-2/PP1alpha association strongly decreased Bcl-2 and Bad-associated phosphatase activity and formation of the trimolecular complex. These results suggest that Bcl-2 targets PP1alpha to Bad.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390485     DOI: 10.4049/jimmunol.166.12.7345

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1.

Authors:  Miriam Llorian; Monique Beullens; Isabel Andrés; Jose-Miguel Ortiz; Mathieu Bollen
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

2.  Protein phosphatase-1 inhibitor-3 is an in vivo target of caspase-3 and participates in the apoptotic response.

Authors:  Hua-Shan Huang; Ernest Y C Lee
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

3.  Suppression of IP3-mediated calcium release and apoptosis by Bcl-2 involves the participation of protein phosphatase 1.

Authors:  Liping Xu; Dejuan Kong; Liping Zhu; Weijia Zhu; David W Andrews; Tuan H Kuo
Journal:  Mol Cell Biochem       Date:  2006-07-28       Impact factor: 3.396

4.  CIN85 interacting proteins in B cells-specific role for SHIP-1.

Authors:  Tom Büchse; Nikolaus Horras; Eva Lenfert; Gerald Krystal; Sandra Körbel; Michael Schümann; Eberhard Krause; Stefan Mikkat; Markus Tiedge
Journal:  Mol Cell Proteomics       Date:  2011-07-01       Impact factor: 5.911

5.  uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.

Authors:  Rama Rao Malla; Sreelatha Gopinath; Christopher S Gondi; Kiranmai Alapati; Dzung H Dinh; Andrew J Tsung; Jasti S Rao
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

6.  Activation of brain protein phosphatase-1(I) following cardiac arrest and resuscitation involving an interaction with 14-3-3 gamma.

Authors:  Jimcy Platholi; Paul M Heerdt; H Y Lim Tung; Hugh C Hemmings
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

7.  Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death.

Authors:  Soumya Sinha Roy; Muniswamy Madesh; Erika Davies; Bruno Antonsson; Nika Danial; György Hajnóczky
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

Review 8.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.

Authors:  Hamdollah Sharifi; Alireza Mohajjel Nayebi; Safar Farajnia; Rasool Haddadi
Journal:  Adv Pharm Bull       Date:  2015-11-30

10.  Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy.

Authors:  Issam Arrouss; Fariba Nemati; Fernando Roncal; Marie Wislez; Karim Dorgham; David Vallerand; Nathalie Rabbe; Narjesse Karboul; Françoise Carlotti; Jeronimo Bravo; Dominique Mazier; Didier Decaudin; Angelita Rebollo
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.